Insulin glargine and lixisenatide Subcutaneous and Primaxin IM
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Primaxin IM and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: cilastatin / imipenem
Brand name: Primaxin IV, Primaxin IM, Primaxin IV ADD-Vantage
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Primaxin IV
- Insulin glargine and lixisenatide Subcutaneous-Prime Health Kids
- Insulin glargine and lixisenatide Subcutaneous-Primene
- Insulin glargine and lixisenatide Subcutaneous-Primidone
- Insulin glargine and lixisenatide Subcutaneous-Primlev
- Insulin glargine and lixisenatide Subcutaneous-Primsol
- Primaxin IM-Insulin glargine, recombinant Subcutaneous
- Primaxin IM-Insulin glulisine
- Primaxin IM-Insulin Glulisine (Cartridges and Pens)
- Primaxin IM-Insulin Glulisine (Vials)
- Primaxin IM-Insulin glulisine Subcutaneous
- Primaxin IM-Insulin human inhaled Inhalation